Author

Yinyu Ma

Fudan University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell type annotation· 1 Organism:human· 1 Organism:mouse· 1 Assay:multiome· 1 Assay:proteomics· 1

Frequent Co-Authors

Changyou ZhaniD· 2 shared Guanghui LiiD· 2 shared Zhiwei Guo· 2 shared Zui ZhangiD· 2 shared Anqi WeiiD· 1 shared Bin Wang· 1 shared Dexuan LeiiD· 1 shared Ercan Wu· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Changyou ZhanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pulmonary mRNA-LNP Vaccines for Rapid and Durable Protection Against Bacterial Infection

Anqi Wei, Yu Miao, Zhou Yuan, Guanghui Li, Dexuan Lei, Yinyu Ma, Zhiwei Guo, Y W Sun, Tianhao Ding, Kaisong Tian, Qin He, Zui Zhang, Lianfeng Fan, Changyou Zhan, Xiaoli Wei

This paper develops a pulmonary mRNA-LNP vaccine that provides rapid and durable protection against bacterial lung infections by integrating innate and adaptive immune responses.

Nature Communications · Jul 8, 2026Peer-reviewedBioengineering

Hydroxy polyethylene glycol: a solution to evade human pre-existing anti-PEG antibodies for efficient delivery

Tianhao Ding, Jiaru Fu, Min Yang, Zui Zhang, Yinyu Ma, Ercan Wu, Zhiwei Guo, Shiqi Lin, Songli Wang, Xiaohua Liu, Weiping Wang, Bin Wang, Guanghui Li, Changyou Zhan

This study shows that hydroxy PEG (OH-PEG) reduces binding to pre-existing anti-PEG antibodies, improving stability and reducing immunogenicity of PEGylated nanomedicines.

ACS Nano · Jun 9, 2026Peer-reviewedPharmacology & Toxicology